ArticlePloS one2024

Generation of murine tumor models refractory to αPD-1/-L1 therapies due to defects in antigen processing/presentation or IFNγ signaling using CRISPR/Cas9.

Paul L Chariou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.